Display Settings:

Format

Send to:

Choose Destination
    Nat Genet. 2001 Jul;28(3):207-9.

    Consent and privacy in pharmacogenetic testing.

    Source

    School of Law, The University of Texas, Austin, Texas 78705, USA. jrobertson@mail.law.utexas.edu

    Abstract

    The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests for disease mutations, they might still reveal personal information that could be used adversely to a patient's interests. Informed consent and privacy of pharmacogenetic test results may be essential in most clinical uses of pharmacogenetic drugs.

    PMID:
    11431685
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk